Detalhe da pesquisa
1.
Crohn's disease in patients treated with etanercept.
Rev Esp Enferm Dig
; 112(1): 80-81, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31793319
2.
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885.
J Clin Med
; 11(19)2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233844
3.
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.
J Clin Med
; 11(15)2022 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35956133
4.
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Inflamm Bowel Dis
; 28(11): 1725-1736, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35166347
5.
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
J Clin Med
; 10(13)2021 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209680
6.
Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week
Rev. esp. enferm. dig
; 114(12): 708-712, diciembre 2022. tab, graf
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-213522
7.
Enfermedad de Crohn ileal en paciente en tratamiento con etanercept / No disponible
Rev. esp. enferm. dig
; 112(1): 80-81, ene. 2020.
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-196021